A survey done by the New York Thoroughbred Horsemen's Association in January found that 81% of its members expected to race fewer times if a ban on race-day Lasix is extended to all overnight races.
With a potential ban of Lasix trainer Ron Moquett joins the TDN Writers’ Room presented by Keeneland to discuss ...
There are many paths HISA officials can take between now and May 22 when they have to fish or cut bait on the use of Lasix in Thoroughbred race horses. Right now, the diuretic may not be used on ...
Asked to assess the past three years when Lasix was not permitted in 2-year-old races or in stakes races, 68 people (or 46.6% of respondents) said they had seen an increase in both the number and ...
While GLP-1 medications are revolutionary for weight loss, they secretly suppress your thirst signals, putting your kidneys ...
Esperion has acquired Corstasis Therapeutics and its nasal spray Enbumyst, which was approved by the FDA six months ago.
The agreement will see Esperion, via a subsidiary, purchase all outstanding stock of Corstasis for an upfront cash payment of ...
Enbumyst™ Is the First and Only FDA-Approved Nasal Spray Loop Diuretic for Edema Associated with Congestive Heart Failure, Expected to ...
Corstasis shareholders also will be eligible to receive a total of up to an additional $180 million upon the attainment of ...
Ann Arbor-based drug maker Esperion Therapeutics Inc. announced Tuesday it signed a definitive agreement to acquire Nevada-based biopharmaceutical company Corstasis Therapeutics.
A World War two-era prequel series, a movie set overseas featuring current cast, and season 16 are all in the pipeline. But the end of the series as we have known it since 2012, when it first debuted, ...
Enbumyst is a nasal spray diuretic to treat edema associated with congestive heart failure and hepatic and renal disease. It was approved by the Food and Drug Administration in September. Corstasis is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results